John Robin Crouse III, MD

Professor, Internal Medicine-Endocrinology/Metabolism and  Public Health Sciences-Epidemiology

Director, Preventive Cardiology; Associate Director, General Clinical Research Center

Email: jrcrouse@wfubmc.edu

Education:

University of Michigan, BS, 1961

State University of New York, MD, 1969

New York Hospital, Residency, 1970-1973

The Rockefeller University, Fellowship, 1973-1976

Board Certification:

American Board of Internal Medicine, 1973

Current Research:

Dr. Crouse is a past recipient of the Preventive Cardiology Academic Award from NHLBI and is director of the Wake Forest University Preventive Cardiology Program. The Preventive Cardiology Program involves clinical activities (the Clinical Lipid Center, a tertiary referral clinic for difficult to manage dyslipidemia patients), research, and teaching. Dr. Crouse has had continuous NIH funding for his research for over 15 years. Research interests include lipids, nutrition, and interrelationships of atherosclerosis of and risk factors for cerebrovascular, peripheral vascular, and coronary artery disease with an emphasis on non-invasive imaging of vascular disease. Dr. Crouse’s important academic contributions include establishment of use of B-mode ultrasound for quantification of subclinical atherosclerosis in epidemiologic studies and clinical trials, and identification of statin treatment as a means of reducing risk of stroke. Current NIH-funded research includes (1) an epidemiologic evaluation of ability of MRI to identify carotid plaque in patients with and without coronary artery disease, and (2) a clinical trial of effects of intense diabetes control to reduce cardiovascular events.  The Preventive Cardiology Program also hosts a yearly Continuing Medical Education program, the Chetola Conference, devoted to dyslipidemia and vascular disease prevention.

Recent Publications:

Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007 Mar 28;297(12):1344-53. Epub 2007 Mar 25.

Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; METEOR Study Group. Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study. Curr Med Res Opin. 2007 Mar;23(3):641-8.

Crouse JR 3rd, Elam MB, Robinson JG, Ambrosius WT, Ginsberg HN. Cholesterol management: targeting a lower low-density lipoprotein cholesterol concentration increases adult treatment panel-III goal attainment. Am J Cardiol. 2006 Jun 1;97(11):1667-9. Epub 2006 Apr 19.

Crouse JR 3rd, Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. J Lipid Res. 2006 Aug;47(8):1677-99. Epub 2006 May 16. Review.

Crouse JR 3rd, Coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005 Aug 18;353(7):735-7; author reply 735-7.

Publications:
For a listing of additional publications, refer to PubMed, a service provided by the National Library of Medicine